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Abstract. After synaptic vesicles fuse with the plasma 
membrane and release their contents, vesicle mem- 
brane proteins recycle by endocytosis and are targeted 
to newly formed synaptic vesicles. The membrane traf- 
fic of an epitope-tagged form of VAMP-2 (VAMP- 
TAg) was observed in transfected ceils to identify se- 
quence requirements for recycling of a synaptic vesicle 
membrane protein. In the neuroendocrine PC12 cell 
line VAMP-TAg is found not only in synaptic vesicles, 
but also in endosomes and on the plasma membrane. 
Endocytosis of VAMP-TAg is a rapid and saturable 
process. At high expression levels VAMP-TAg accu- 
mulates at the cell surface. Rapid endocytosis of 
VAMP-TAg also occurs in transfected CHO cells and 
is therefore independent of other synaptic proteins. 
The majority of the measured endocytosis is not di- 
rectly into synaptic vesicles since mutations in VAMP- 
TAg that enhance synaptic vesicle targeting did not af- 
fect endocytosis. Nonetheless, mutations that inhibited 
synaptic vesicle targeting, in particular replacement of 
methionine-46 by alanine, inhibited endocytosis by 
85% in PC12 cells and by 35% in CHO cells. These re- 
sults demonstrate that the synaptic vesicle targeting sig- 
nal is also used for endocytosis and can be recognized 
in cells lacking synaptic vesicles. 
S 
IGNALS in the cytoplasmic domains of membrane pro- 
teins are often required for endocytosis. The most 
common type of endocytosis signal contains an es- 
sential tyrosine exposed by a type 1 13-turn and promotes 
internalization by interacting with the AP2 adaptor pro- 
teins of clathrin-coated pits (reviewed in Trowbridge et al., 
1993). Another class of signals that can promote endocyto- 
sis has a dileucine motif (Letourneur and Klausner, 1992). 
Membrane proteins also often contain additional signals 
adjacent to or overlapping their endocytosis signals that 
direct them to other destinations on their membrane traf- 
ficking itineraries. We have recently reported the identifi- 
cation of a signal for targeting an epitope-tagged form of 
VAMP-2  (VAMP-TAg)  1  to  synaptic  vesicles  in  trans- 
fected PC12 cells (Grote et al., 1995). This synaptic vesicle 
targeting signal (SVTS) requires hydrophobic amino acids 
within  a  predicted  amphipathic  helix.  Point  mutations 
within the SVTS can either increase or decrease the frac- 
tion of VAMP-TAg sorted to synaptic vesicles. No signals 
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homologous to the SVTS are found in other synaptic vesi- 
cle membrane proteins, so there cannot be a common sort- 
ing receptor analogous to the coated pit adaptors that is 
responsible for synaptic vesicle targeting. As an alterna- 
tive, we suggested that VAMP-TAg is targeted to synaptic 
vesicles by associating, via the SVTS, with other synaptic 
vesicle membrane proteins. 
VAMP-2,  also known as synaptobrevin-2, is an 18-kD 
COOH-terminal anchored synaptic vesicle protein with a 
critical role in vesicle fusion (Trimble, 1993).  Cleavage of 
VAMP-2  by the metalloprotease subunit of the  tetanus 
neurotoxin blocks synaptic vesicle exocytosis (Schiavo et 
al.,  1992).  VAMP-2 is one component of a trimeric com- 
plex known as a SNAP receptor, or SNARE, because it 
serves as a binding site for c~-SNAP and NSF, two compo- 
nents of the intracellular fusion machinery (Sollner et al., 
1993).  Since VAMP-2 is a  synaptic vesicle protein while 
the other components of the SNARE complex, syntaxin 
and SNAP-25, are primarily located on the plasma mem- 
brane, the SNARE complex may bridge the short gap be- 
tween a docked synaptic vesicle and the plasma membrane 
before the fusion event. There is a growing family of pro- 
teins homologous to VAMP-2 that are targeted to distinct 
populations of transport vesicles and are  collectively re- 
ferred to as v-SNAREs. The v-SNAREs on each class of 
transport  vesicle  form SNARE  complexes with specific 
t-SNAREs on their unique targets for membrane fusion. 
Thus, SNARE complex formation may play a role in regu- 
lating the  specificity of membrane fusion.  GTP binding 
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geted  to  distinct  populations  of  transport  vesicles  and 
thought to regulate the specificity of membrane fusion, are 
required  in  vivo  for  v-SNARE  activation and  SNARE 
complex formation (Lian et al., 1994; Sogaard et al., 1994). 
The domain of VAMP-2 that is most highly conserved 
between species, among VAMP isoforms, and with other 
v-SNAREs  is  located  in  the  cytoplasm adjacent to  the 
transmembrane anchor. This domain is required for both 
synaptic vesicle targeting and t-SNARE binding (Hayashi 
et al., 1994; Grote et al., 1995). However, the sequences re- 
quired for these two functions can be distinguished by mu- 
tations that block or enhance synaptic vesicle targeting but 
not t-SNARE binding (Grote et al., 1995). The juxtamem- 
brane domain of cellubrevin, a v-SNARE for recycling en- 
dosomes,  is  96%  identical  to  the  analogous  domain  of 
VAMP-2 (McMahon et al., 1993). Although cellubrevin is 
found in many cell types, it is targeted to synaptic vesicles 
when expressed in neuroendocrine cells (Chilcote et al., 
1995; Grote et al., 1995). The promiscuous targeting of cel- 
lubrevin implies that synaptic vesicles and recycling endo- 
somes cannot be differentially targeted for fusion by their 
respective v-SNAREs as proposed in the original presen- 
tation of the SNARE hypothesis. 
After  exocytosis, synaptic  vesicle  membranes  recycle 
within the nerve terminal (Holtzman et al., 1971). Endocy- 
tosis is certainly required for synaptic vesicle recycling, but 
the exact pathway of recycling is unknown. The simplest 
possible mechanism would be to reverse the opening of a 
transient fusion pore after neurotransmitters are released 
(Alvarez de Toledo et al., 1993). However, at least in some 
cases, synaptic vesicles do fuse completely with the plasma 
membrane (Heuser and Reese, 1973; von Gersdorff and 
Matthews, 1994). Clathrin-coated vesicles probably have a 
major role in synaptic vesicle recycling since the predomi- 
nant membrane proteins identified in coated vesicles from 
nerve terminals  are  synaptic vesicle membrane proteins 
(Maycox et al., 1992).  After disassembly of their clathrin 
coats, primary endocytotic vesicles generally fuse with en- 
dosomes. Endosomes could function as a sorting station in 
the vesicle recycling pathway where synaptic vesicle pro- 
teins are segregated away from other proteins that either 
recycle back to the plasma membrane or return to the cell 
body by retrograde axonal transport. Alternatively, trans- 
port through an endosomal intermediate may be unneces- 
sary if synaptic vesicle proteins are segregated before en- 
docytosis. Synaptic vesicles might recycle by more  than 
one pathway in nerve terminals. Routine recycling could 
occur by budding from the plasma membrane immediately 
after  recycling  while  missorted  proteins  and  proteins 
newly delivered from the cell body are sorted to synaptic 
vesicles within endosomes (Jahn and Sudhof, 1993). 
PC12 pheochromocytoma cells have vesicles analogous 
to synaptic vesicles and have been used for studies of syn- 
aptic vesicle biogenesis because of their accessibility and 
ability to express transfected proteins. PC12 synaptic vesi- 
cles contain all of the general synaptic vesicle membrane 
proteins and are similar in their physical properties to the 
synaptic vesicles of rat brain  (Wiedenmann et  al.,  1988; 
Clift-O'Grady et al., 1990; Cameron et al., 1991). Synaptic 
vesicle  proteins  recycle  from  the  plasma  membrane  to 
PC12 synaptic vesicles by a process that excludes markers 
of other endocytotic pathways such as the transferrin re- 
ceptor (Clift-O'Grady et al.,  1990). Since a large fraction 
of the synaptophysin in PC12 cells is present in endosomal 
organelles that also contain the transferrin receptor, it has 
been proposed that PC12 synaptic vesicles bud from endo- 
somes (Cameron et al., 1991; Linstedt and Kelly, 1991). In 
support of this proposal, a kinetic lag has been observed 
before the fluid phase endocytosis marker HRP can be de- 
tected in synaptic vesicles (Bauerfeind et al., 1993). Thus, 
at least in PC12 cells, synaptic vesicle membrane proteins 
are  probably internalized to endosomes before they are 
sorted to synaptic vesicles. This two-step recycling process 
suggested to us that synaptic vesicle membrane proteins 
may have two distinct targeting signals that act sequen- 
tially. 
CHO cells are commonly used to study the behavior of 
synaptic vesicle proteins in cells that lack synaptic vesicles. 
It is generally assumed that membrane traffic in CHO cells 
is identical to that in PC12 cells except for the absence of 
the  machinery  for  biogenesis  of  synaptic  vesicles  and 
secretory granules. In previous studies of CHO cells trans- 
fected with synaptic vesicle proteins it has been reported 
that synaptophysin is targeted to early endosomes, synap- 
totagmin remains on the cell surface associated with focal 
adhesions, and SV2 is targeted to intracellular organelles 
distinct from those containing synaptophysin (Johnston et 
al.,  1989; Feany and Buckley, 1993; Feany et  al.,  1993). 
When the three proteins are cotransfected they still target 
to distinct organelles and do not associate with each other 
or induce the formation of synaptic vesicles (Feany et al., 
1993). Since CHO cells do not have the machinery for syn- 
aptic vesicle biogenesis it is  uncertain  whether they ex- 
press the "sortase" that binds to the SVTS of VAMP. Al- 
though CHO cells would not be expected to recognize a 
signal dedicated for synaptic vesicle targeting, they might 
still  recognize  the  SVTS  since  it  is  conserved  in  cellu- 
brevin. 
In this paper we  report  the  results of our attempt to 
identify a  signal  for VAMP-TAg  endocytosis using  the 
comprehensive  collection  of  mutations  created  for  the 
identification of the SVTS. Instead of identifying a distinct 
endocytosis signal, we  discovered that  mutations in the 
SVTS inhibit endocytosis in PC12 cells in addition to syn- 
aptic vesicle targeting. We also found that endocytosis of 
VAMP-TAg in CHO cells is rapid and partially dependent 
on the SVTS. These results suggest that the SVTS is a gen- 
eral signal for v-SNARE recycling. 
Materials and Methods 
Cell Culture, Transfection, cDNAs, Antibodies, 
and Iodination 
Conditions for growth and transfection of PC12 cells, construction of the 
wild-type and mutant VAMP-TAg expression vectors, and the purifica- 
tion and iodination of the KT3 monoclonal antibody have been previously 
described (Grote et al., 1995). CHO cells were grown in DME H-21 media 
supplemented with 5% fetal calf serum and were transfected by electropo- 
ration using 250 ~F capacitors charged to 300 inV. Expression vectors for 
the  wild-type  and  mutant  polymeric immunoglobulin receptor  (plgR) 
variants and FAB fragments of a polyclonal antibody to the lumenal do- 
main of the plgR were the generous gift of C. Okamoto and K. Mostov 
(Okamoto et al., 1992). The anti-plgR FAB'S  were iodinated to 20 IxCi/mg 
using the ICI method (Breitfeld et al., 1989). 
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PC12/VAMP-TAg cells were plated on poly-D-lysine-coated glass cover- 
slips or on Matrigel (Collaborative Research) coated chamber slides 2 d 
before  staining. To  observe  total  VAMP-TAg staining, the  cells  were 
washed in PBS and fixed with 3% paraformaldehyde in PBS. Fixed cells 
were permeabilized with 0.1% Saponin in PBS/I%  BSA, incubated with 
the KT3 monoclonal antibody in permeabilization buffer, and detected 
with fluorescein-conjugated goat anti-mouse IgG  (Cappel). For the im- 
munofluorescent endocytosis assay, cells  were  incubated  with  2  p.g/ml 
KT3 in DME H-21, 20 mM Hepes, pH 7.4, for 5 rain at 37°C, then washed 
with 125 mM NaC1, 20 mM glycine, pH 2.4, at 4°C to remove surface stain- 
ing. To visualize internalized KT3, the cells were fixed, permeabilized, and 
stained with fluorescein-conjugated secondary antibodies as above. 
Endocytosis  Measurements with NHS-SS-biotin 
Cell surface proteins were labeled with NHS-SS-biotin (Pierce), warmed 
to 37°C for the indicated times, and then biotin remaining on the cell sur- 
face was removed by washing in glutathione (Lisanti et al., 1990).  Cells 
were lysed in IP buffer (1%  NP-40 0.5%  deoxycholate, 150 mM NaCl, 
10 mM Tris-HC1, pH 7.8) and insoluble aggregates were removed in a 15 
min, 16,000 g pellet. Biotinylated proteins from clarified lysate equivalent 
to  1/4  of a  3.5-cm dish were  collected  with  50  ixl streptavidin-agarose 
beads (Sigma), eluted in nonreducing sample buffer and resolved by SDS- 
PAGE. VAMP-TAg was detected on immunoblots probed with KT3 anti- 
bodies using a  chemiluminescent detection system (Amersham). KT3 
(8 i~g/ml) was present during the washing and incubation steps where indi- 
cated. 
Endocytosis  Measurements with Iodinated Antibodies 
Transfected cells were replated on poly-o-lysine-coated dishes 1 d before 
the assay. Cells were incubated with up to 107 cpm/ml [125I]-antibody  (<2 
i~g/ml)  in PBS/5%  BSA for 45 min at 4°C. Unbound antibody was re- 
moved by extensive washing in PBS/BSA at 4°C. The cells were next incu- 
bated in PBS/BSA at 37°C for various times to allow endocytosis and then 
returned to 4°C. Antibody remaining at the ceil surface was removed by 
two 15-min washes at 4°C in PBS/BSA supplemented with 30 mM glycine 
and adjusted to pH 2.4. Acid-resistant antibody was collected by lysing the 
cells with IP buffer and then scraping them from the dish. The fraction of 
[125I]-KT3 internalized was calculated by dividing the acid wash resistant 
radioactive counts per minute (cpm) by the sum of acid wash resistant and 
accessible cpm. 10%  of the [~zSI]KT3 was resistant to the acid stripping 
procedure in both cells left at 4°C and in paraformaldehyde fixed cells. 
This background was subtracted when comparing endocytosis rates of the 
VAMP-TAg mutants. No  correction  was  made for  the dissociation of 
[125I]-KT3 from cells that inevitably occurs during the course of the assay. 
The rate of dissociation of [125I]-KT3 increases from 0.3% per minute at 
4°C  to  2%  per  minute  at  37°C.  Since  antibody  that  dissociates from 
VAMP-TAg within an endosome remains cell associated until the endo- 
some recycles to the cell surface, whereas antibody that dissociates from 
VAMP-TAg at the plasma membrane is released immediately into the 
media, the calculated fraction of internal  [125I]KT3 is artificially high at 
late time points. 
Cell Surface Fraction Measurements 
with NHS-SS-Biotin 
Cells were labeled at 4°C with NHS-SS-Biotin and a clarified lysate was 
prepared  in IP buffer. VAMP-TAg and VAMP-2 were immunoprecipi- 
tated with the 69.1  anti-VAMP-2 antibody and protein G  agarose beads 
and eluted from the precipitated  complex by boiling for 5  min in  10% 
SDS. An aliquot of total VAMP immunoprecipitate was set aside. The re- 
mainder of the eluted immunoprecipitate was diluted 60-fold in 2.5% Tri- 
ton  X-100,  125  mM NaCl  and  biotinylated proteins were  collected  on 
streptavidin-agarose beads.  Proteins were  eluted from the streptavidin- 
agarose beads by boiling in sample buffer with 750 mM 13-mercaptoetha- 
nol and resolved by SDS-PAGE. Total and biotinylated VAMP-TAg and 
VAMP-2 were detected on immunoblots with the 69.1 monoclonal anti- 
body. 
Cell Surface Fraction Measurements with [125I]KT3 
Cells were plated on poly-L-lysine-coated dishes, fixed in 3% paraformal- 
dehyde in PBS, and incubated with [12~I]-KT3 in PBS/5% BSA in the pres- 
ence or absence of 0.05% saponin. After seven washes in PBS/BSA (with 
or without saponin), the cells were collected in IP buffer as above. The 
fraction on the cell surface was calculated by dividing the cpm bound to 
the surface of fixed cells by the cpm bound when internal KT3 binding 
sites were made accessible by permeabilization of membranes with sapo- 
nin. Initial experiments demonstrated that the total cpm bound to cells in- 
creased proportionally to the saponin concentration until reaching a pla- 
teau at 0.04% saponin. 
Results 
Targeting and Transport of VAMP-TAg to Endosomes 
VAMP-TAg  was  constructed  by appending  an  8-amino 
acid epitope from the  SV-40 T  antigen and  a  14-amino 
acid spacer to the COOH terminus of rat VAMP-2 (Grote 
et al.,  1995).  Since only 2%  of the total VAMP-TAg in 
transfected PC12 cells was recovered in synaptic vesicles, 
immunofluorescent microscopy was used to identify where 
the remainder of the transfected VAMP-TAg is targeted. 
Stably transfected PC12/VAMP-TAg cells  (Grote et al., 
1995)  were stained  with  the  KT3 monoclonal antibody, 
which binds to the epitope tag  (MacArthur and Walter, 
1984). In saponin-permeabilized cells VAMP-TAg was ob- 
served in punctate organelles concentrated in the perinu- 
clear region of the cell and at the cell surface (Fig. 1). Sur- 
face staining was more apparent in nonpermeabilized cells 
(data not shown). No staining was observed in nontrans- 
fected cells. 
The distribution of VAMP-TAg in PC12 cells is similar 
to the staining pattern of synaptophysin and the transfer- 
rin receptor, two proteins that colocalize in  early endo- 
somes (Cameron et al., 1991). To determine if VAMP-TAg 
is  also  found  in  an  endosome, VAMP-TAg  transfected 
PC12 cells were incubated with KT3 monoclonal antibody 
for 5 min at 37°C.  Antibody remaining bound to the cell 
surface was removed by a low pH wash at 4°C and the cells 
were fixed, permeabilized, and then stained with fluores- 
cent secondary antibodies.  Internalized VAMP-TAg was 
observed in punctate organelles concentrated in the peri- 
nuclear region similar  to those stained in  permeabilized 
Figure 1.  Immunofluorescent labeling of steady-state and inter- 
nalized  VAMP-TAg  in  PC12  cells.  (a)  Total  VAMP-TAg  was 
stained by indirect immunofluorescence using the KT3 mAb. (b) 
To  detect  endosomal  VAMP-TAg,  cells  were  incubated  with 
KT3 mAb  for 5  min at  37°C and washed in acidic buffer at 4°C 
before fixation. 
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fected  ceils.  The  similarity  in  the  staining  patterns  of 
VAMP-TAg at steady-state and after internalization sug- 
gests that a large fraction of VAMP-TAg is targeted to en- 
dosomes in transfected PC12 cells. 
KT3 is a bivalent antibody and might potentially cross- 
link VAMP-TAg and alter its subcellular distribution. In 
lymphocytes, cross-linking induces capping and  internal- 
ization  (Schreiner  and  Unanue,  1976).  An  attempt  was 
made to observe VAMP-TAg endocytosis using monova- 
lent FAB fragments of the KT3 monoclonal antibody to ex- 
clude the possibility that the VAMP-TAg internalization 
observed above was artificially induced by cross-linking. 
Unfortunately, the affinity of the KT3 FAB'S was insuffi- 
cient  to  observe internalization.  An  alternate  approach 
was therefore adopted using the membrane impermeable 
surface labeling reagent NHS-SS-biotin to determine the 
effect of KT3 on VAMP-TAg endocytosis. Biotinylation 
of VAMP-TAg is unlikely to affect KT3 binding since the 
KT3 epitope does not contain any free amino groups with 
the potential to react with NHS-SS-biotin. Proteins at the 
cell surface of VAMP-TAg transfected PC12 cells were bi- 
otinylated at 4°C, then warmed to 37°C in the presence or 
absence of bivalent KT3 at four times the concentration 
used to observe endocytosis. At various time points the 
ceils were returned to 4°C and biotin was stripped from 
proteins remaining at the cell surface by reduction of the 
disulfide bond with glutathione. Internalized VAMP-TAg 
was collected on streptavidin-agarose beads and detected 
on immunoblots with  KT3 (Fig.  2).  The results demon- 
strate that VAMP-TAg internalization was not induced by 
KT3 antibodies. Thus, bivalent KT3 can be used to mea- 
sure the basal rate of VAMP-TAg internalization. 
Endocytosis of VAMP-TAg Is Rapid and Saturable in 
PC12 Cells 
A  quantitative assay using iodinated KT3 was developed 
to measure the rate of VAMP-TAg endocytosis. For this 
assay, the pool of VAMP-TAg on the plasma membrane 
was labeled at 4°C with [125I]-KT3. Binding of [125I]-KT3 to 
VAMP-TAg at the cell surface is specific since 15 times 
more [t25I]-KT3 bound to PC12/VAMP-TAg cells than to 
nontransfected PC12 cells. After warming to 37°C for vari- 
ous times [t25I]-KT3 remaining at the cell surface was re- 
moved by a low pH wash and the fraction of antibody re- 
sistant to the acid wash due to endocytosis was calculated. 
Internalization  of  [125I]-KT3 in  PC12/VAMP-TAg  cells 
Figure  2.  VAMP-TAg  en- 
docytosis  occurs  indepen- 
dently  of  KT3.  Proteins  on 
the  plasma  membrane  of 
PC12/VAMP-TAg cells were 
labeled at 4°C with the mem- 
brane impermeable reagent NHS-SS-biotin. The cells were then 
incubated with or without KT3 antibodies at four times the stan- 
dard concentration. After incubation at 37°C for the indicated 
times (in minutes), biotin was stripped from proteins remaining 
at the cell surface with glutathione. Biotinylated proteins pro- 
tected from reduction by endocytosis were collected on strepta- 
vidin-agarose, and internalized VAMP-TAg was detected by im- 
munoblotting with KT3 antibodies. 
was rapid, proceeding at an initial rate of 19% per minute 
(Fig. 3). 
Internalization of [125I]-KT3 was also measured in PC12 
cells  transiently  transfected  with  VAMP-TAg  by  elec- 
troporation. Compared with the clonal PC12/VAMP-TAg 
cell line, the  rate  of VAMP-TAg  endocytosis was  rela- 
tively slow in transiently transfected PC12 cells. One possi- 
ble explanation for this observation is that the pathway for 
VAMP-TAg endocytosis is  saturated  at  high  expression 
levels. To determine if the expression level of VAMP-TAg 
in  transiently transfected cells is  high  enough  to poten- 
tially  saturate  the  endocytosis  pathway,  the  expression 
level of VAMP-TAg was compared with the native  ex- 
pression level of VAMP-2. The mean expression level of 
VAMP-TAg in PC12 cells transfected with 75 ~g of the 
pRC/CMV/VAMP-TAg  expression  vector  is  approxi- 
mately twofold greater than that of VAMP-2, and similar 
to  the  expression  level  of  VAMP-TAg  in  the  PC12/ 
VAMP-TAg cell line.  However, only 20%  of the  PC12 
ceils that survive electroporation express enough VAMP- 
TAg to be detected by immunofluorescent staining (data 
not shown). Thus, the mean expression level in the subset 
of cells expressing VAMP-TAg after transient transfection 
is elevated to ~10 times the expression level of VAMP-2. 
To measure the effect of expression level on the rate of 
VAMP-TAg endocytosis, internalization of [125I]-KT3 was 
assayed in PC12 cells transiently transfected with varied 
amounts of the pRC/CMV/VAMP-TAg expression vector. 
Increasing the amount of VAMP-TAg cDNA resulted in 
increased binding of [125I]-KT3 to the cell surface of trans- 
fected cells (Fig. 4 a). The fraction of [125I]-KT3 internal- 
ized to an acid resistant fraction during 3 min at 37°C was 
inversely proportional to the VAMP-TAg expression level 
(Fig. 4 b). This result indicates that the endocytosis path- 
way is saturable and implies that a limiting component is 
required for rapid endocytosis. At the highest total expres- 
sion  level, the fraction of [125I]-KT3 internalization in  3 
min did not fall below 0.2.  This suggests that there may 
also  be  a  slow,  nonsaturable  VAMP-TAg  endocytosis 
pathway. However, since populations of transiently trans- 
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Figure 3.  Quantitative measurement of VAMP-TAg endocytosis 
in PC12 cells. Internalization measurements were made by deter- 
mining the fraction of radioiodinated antibody that was internal- 
ized to an endosomal compartment resistant to an acid wash. Er- 
ror bars represent the standard deviation, n  =  3.  Deviations of 
less than 0.015 are not displayed. 
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Figure 4.  Endocytosis of VAMP-TAg is saturable.  (a) Titration 
of  VAMP-TAg  expression.  PC12  cells  were  transiently  trans- 
fected  by  electroporation  using  various  amounts  of  the  pRC/ 
CMV/VAMP-TAg cDNA expression vector. Surface expression 
was  measured  by  [125I]-KT3  binding.  (b)  VAMP-TAg  overex- 
pression  inhibits  endocytosis.  Endocytosis  of VAMP-TAg was 
measured  after 3  rain  at  37°C.  Measurements  were made  as  in 
Fig. 3 except that background  counts from [I25I]-KT3  binding to 
mock-transfected cells were subtracted. 
fected cells do not have a uniform expression level, an al- 
ternate explanation for the residual internalization at high 
expression  levels  is  that  even  if  the  amount  of  cDNA 
transfected  exceeds  100  Ixg,  a  certain  fraction  of  the 
VAMP-TAg molecules are still expressed in cells where 
the expression level is below that which saturates endocy- 
tosis. 
Involvement of the Synaptic Vesicle Targeting Signal in 
Endocytosis of VAMP-TAg in PC12 Cells 
VAMP-TAg does not contain any sequence motifs with 
obvious  homology  to  previously  identified  signals  for 
coated pit-mediated  endocytosis. Therefore, endocytosis 
rates were measured for members of a comprehensive col- 
lection of VAMP-TAg mutants to identify sequence mo- 
tifs  required  for endocytosis (Fig.  5).  Endocytosis rates 
were first compared in transiently transfected PC12 cells. 
An advantage of using transiently transfected cells is that 
they have a uniform growth rate and do not display clonal 
variability in morphological properties. For the wild-type 
VAMP-TAg construction, 40 I~g of cDNA was used for 
the transfection to give adequate protein expression with- 
out saturating  the endocytosis pathway.  The amount  of 
each  mutant  VAMP-TAg  cDNA  used  was  adjusted  to 
provide approximately equal levels of cell surface expres- 
sion.  Similar concentrations of cDNA were used for ex- 
pression of all of the mutants  with the exception of del 
2-60. 
The  first  set  of mutants  examined  for internalization 
competence  includes  two  large  NH2-terminal  deletions 
(del 2-31  and del 2-60) and a chimera in which the trans- 
membrane domain of VAMP-TAg is replaced by the trans- 
membrane domain of the transferrin receptor (TfR-TM). 
None of these mutants  inhibited endocytosis (Fig.  6  a). 
Since the endocytosis rates for the del 2-31  and TfR-TM 
mutants are actually faster than that of VAMP-TAg, the 
NH2-terminal  and  transmembrane  domains  may  inhibit 
endocytosis. The rapid endocytosis rate of the del 2-60 mu- 
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Figure 5.  Structure  of VAMP-TAg and  the  mutants.  (a)  Sche- 
matic representation  of VAMP-TAg and  the  domain  mapping 
mutations.  The cytoplasmic domain  of VAMP-2 consists  of an 
NH2-terminal variable domain and a conserved domain contain- 
ing two predicted amphipathic a-helices. To create VAMP-TAg, 
an  8-amino  acid  epitope  from  the  SV-40  T  antigen  was  ap- 
pended, via a  14-amino acid spacer,  to the COOH terminus  of 
the transmembrane  anchor. The epitope tag is accessible to anti- 
body  in  the  media  when  VAMP-TAg is  on  the  plasma  mem- 
brane. Two large NH2-terminal deletions and a chimera contain- 
ing the transmembrane  domain of the transferrin receptor were 
constructed  to identify targeting domains.  (b) Mutations  within 
the conserved domain of VAMP-TAg. The sequence of the con- 
served domain  is shown  with  amino  acids  on  the  hydrophobic 
face of the two predicted amphipathic a-helices indicated in bold 
type.  The  synaptic  vesicle targeting  signal (SVTS) is contained 
within helix 1 and is centered on methionine-46 (*). Amino acids 
removed in each internal deletion are indicated. The underlined 
amino acids (41-50) were each mutated, individually, to alanine. 
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Figure  6.  Internalization rates for the VAMP-TAg mutants in 
PC12 cells. (a) Domain mapping mutations.  (b) Internal deletions 
within  the  conserved  domain.  (c)  Alanine  scanning  mutants 
within the synaptic vesicle targeting signal. The internalization  of 
[125I]-KT3 was measured as in Fig. 4 except that a time = 0 back- 
ground of between 0.06 and 0.12 was subtracted for each mutant. 
tant  suggests  that  the  synaptic  vesicle  targeting  signal 
(SVTS)  is  not  required  for  endocytosis,  but  this  result 
must  be cautiously interpreted  since  it was necessary to 
use 300 Ixg of del 2-60 cDNA to have adequate surface ex- 
pression. 
Endocytosis was next measured for a series of VAMP- 
TAg mutants with internal deletions within the conserved 
domain. Included in this group is del 88-90, a mutant that 
lacks the only tyrosine in the cytoplasmic domain. Among 
the internal deletions, the strongest inhibition of endocy- 
tosis was observed for del 41-50, a deletion of the central 
core of the SVTS (Fig. 6 b). Endocytosis was also partially 
inhibited by de151-60, a deletion that lacks the COOH ter- 
minus  of the  predicted  amphipathic helix containing  the 
SVTS. Internalization of a series of VAMP-TAg mutants 
in which amino acids 41-50 were each substituted with ala- 
nine was measured to further define the relationship be- 
tween the  SVTS  and  endocytosis. The Meta6Ala mutant, 
the most potent inhibitor of synaptic vesicle targeting, in- 
hibited endocytosis by 80% (Fig. 6 c). Mutation of Va143 or 
Vals0,  amino acids adjacent to Met46 on the hydrophobic 
face  of the  predicted  amphipathic  helix  comprising  the 
SVTS, also inhibited endocytosis. In contrast to the muta- 
tions  that  blocked  synaptic  vesicle  targeting,  mutations 
such as del 61-70 and Asn49Ala that enhanced targeting to 
synaptic vesicles did not affect the endocytosis rate. This 
result provides indirect support that [125I]-KT3 is internal- 
ized primarily to endosomes rather than to synaptic vesi- 
cles. 
Internalization  of  selected  VAMP-TAg  mutants  was 
also compared in  clonal  PC12-derived cell lines.  In con- 
trast to transiently transfected cells, expression in cell lines 
is not limited to a minority of cells with relatively high ex- 
pression.  The  clonal  cell  lines  selected  for  analysis  ex- 
pressed the del 41-50, MetnrAla and Asn49Ala mutants at 
levels similar to the expression level of VAMP-TAg in the 
PC12/VAMP-TAg cell line. The relative endocytosis rates 
of the mutants in the clonal cell lines paralleled the rates 
observed after transient transfection (Fig. 7). Endocytosis 
was slow for the del 41-50 and Met46Ala mutants but un- 
changed for Asn49Ala. Thus, the reduction in endocytosis 
rates  observed with  mutations  in  the  SVTS  that  inhibit 
synaptic vesicle targeting is not an artifact resulting from 
overexpression of the mutant proteins by transient trans- 
fection. 
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Figure 7.  Internalization of VAMP-TAg mutants in clonal PC12- 
derived cell lines. Cell lines were selected that expressed VAMP- 
TAg proteins with mutations that affect synaptic vesicle targeting 
at expression levels similar to that of VAMP-2. Internalization of 
[125I]-KT3  after 3 min at 37°C was measured as in Fig. 3. 
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Surface Accessibility 
If reductions in the rate of VAMP-TAg endocytosis result 
from defects specific to the endocytotic stage of the recy- 
cling  pathway,  then  VAMP-TAg  should  accumulate  on 
the  plasma membrane when  its  endocytosis  is  inhibited. 
This effect was first observed during screening to identify 
a clonal cell line that expresses the del 41-50 mutation by 
immunofluorescent staining.  Compared to PC12/VAMP- 
TAg cells, PC12-derived cell lines transfected with the del 
41-50 mutant have enhanced surface staining with the KT3 
antibody (Fig. 8). 
The accumulation of the del 41-50 mutant at the plasma 
membrane was confirmed by a  cell surface biotinylation 
assay.  Proteins  on  the  cell  surface of PC12/VAMP-TAg 
and  PC12/del  41-50  cells  were  biotinylated  at  4°C  with 
NHS-SS-Biotin. The total population of VAMPs was im- 
munoprecipitated  with  a  VAMP-2-specific  antibody, 
eluted with SDS, and the fraction of VAMP-TAg from the 
plasma  membrane  was  reprecipitated  with  streptavidin- 
agarose  beads.  Aliquots  of the  total  immunoprecipitate 
and streptavidin-agarose precipitate were resolved on a re- 
ducing polyacrylamide gel and an immunoblot was probed 
with  the  anti-VAMP-2  antibody  (Fig.  9).  The  immuno- 
precipitated  VAMP-2  serves  an  internal  control.  Since 
VAMP-2 lacks reactive amines accessible from outside the 
cell it cannot he biotinylated. Thus, the absence of VAMP- 
2 from the streptavidin-agarose precipitates demonstrates 
the specificity of this method. The results show that the to- 
tal expression level of VAMP-TAg (V) and the del 41-50 
mutant (A) are similar, but that there is more del 41-50 on 
the cell surface. Thus, the surface staining observed for del 
41-50  in  individual  cells by immunofluorescence reflects 
enhanced  accumulation  on  the  plasma membrane in  the 
entire population of transfected cells. 
To quantify the fraction of VAMP-TAg on the cell sur- 
face, the accessibility of the T antigen epitope to [12sI]-KT3 
in paraformaldehyde-fixed cells was compared in the ab- 
sence or presence of saponin, a  detergent that permeabi- 
lizes cell membranes. 3%  of the  total  [12sI]-KT3  binding 
sites in PC12/VAMP-TAg  cells are  accessible in  the  ab- 
Figure 8.  Enhanced  surface  staining  of PC12  cells  transfected 
with the del 41-50 mutant. Immunofluorescent staining with the 
KT3 monoclonal antibody of saponin-permeabilized PC12 clones 
transfected with (a) VAMP-TAg or (b) de141-50. 
Figure 9. Accumulation of the del 41-50 mutant on the surface of 
PC12 cells. Proteins on the cell surface  of clonal PC12-derived 
cell lines expressing VAMP-TAg (V) or the de141-50 mutant (A) 
were labeled at 4°C with NHS-SS-Biotin. VAMPs were collected 
by immunoprecipitation with  an  anti-VAMP-2-specific  mono- 
clonal antibody and eluted from the precipitate with 10% SDS. 
An aliquot  of the total VAMP immunoprecipitate was set aside 
and the remainder of the sample was reprecipitated with strepta- 
vidin-agarose beads and eluted in reducing sample buffer. An im- 
munoblot of the total VAMP precipitates and the biotinylated 
surface fractions was probed with the anti-VAMP-2 antibody. 
sence of saponin. The quantitative results with this  [12sI]- 
KT3 binding assay are consistent with the qualitative ob- 
servations made with the  cell surface biotinylation  assay 
(data not shown). The fraction of [12sI]-KT3 binding sites 
accessible in  the  absence of saponin increased when en- 
docytosis was inhibited by overexpression (Fig. 10 a). Sim- 
ilarly, enhanced  accumulation at the cell surface of tran- 
siently  transfected  PC12  cells  was  observed  for  those 
mutations in  the  SVTS, such as del 41-50  and Met46Ala, 
that inhibit endocytosis (Fig. 10 b). Thus, both overexpres- 
sion of VAMP-TAg and mutation of the SVTS predomi- 
nately  inhibit  endocytosis  rather  than  recycling  to  the 
plasma membrane. 
VAMP-TAg Endocytosis in CHO Cells 
To determine if neuroendocrine-specific components such 
as  other  synaptic vesicle  proteins  or  specialized compo- 
nents of clathrin-coated pits are required for VAMP-TAg 
endocytosis,  internalization  was  measured  in  transiently 
transfected CHO cells (Fig. 11 a). The rapid initial rate of 
VAMP-TAg  internalization  in  CHO  cells  implies  that 
VAMP-TAg contains a cell type-independent endocytosis 
signal. The role of the SVTS in VAMP-TAg endocytosis 
in  CHO cells was tested by comparing internalization  of 
the wild-type and Met46Ala mutant VAMP-TAg proteins. 
The  Met46Ala  mutation  inhibited  endocytosis  by  35% 
(Figure 11 b). The inhibitory effect of the mutation dem- 
onstrates  that  CHO  cells  express components that  can 
interact with the  SVTS.  However, the  35%  inhibition  in 
CHO cells is small compared to the 85% inhibition of en- 
docytosis  observed  for  the  Met46Ala  mutation  in  PC12 
cells. 
The cell type-dependent differences in the extent of in- 
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Figure  10.  Accessibility  of VAMP-TAg to  [125I]-KT3 surface 
binding.  (a) Overexpressed VAMP-TAg accumulates at the ceil 
surface. The fraction of VAMP-TAg on the cell surface was mea- 
sured for PC12 cells transiently transfected with various concen- 
trations of cDNA. Cells were fixed with paraformaldehyde, incu- 
bated  in  []2sI]-KT3  labeling  media  with  or  without  0.05% 
saponin, and then washed. The fraction of [t25I]-KT3 binding sites 
on the cell surface was calculated by dividing  the cpm bound to 
cells in the absence of saponin by the cpm bound with saponin. 
(b) VAMP-TAg mutants defective for endocytosis accumulate at 
the cell surface.  PC12 cells were transiently transfected with 40 
I~g cDNA coding for selected VAMP-TAg mutants. To normal- 
ize for subtle variations in expression level, the fraction of surface 
accessible  [125I]-KT3  binding sites was divided by the total [125I]- 
KT3 cpm bound. Accumulation of the del 41-50 and Metn6Ala 
mutants on the cell surface was apparent with or without this cor- 
rection. Error bars represent the standard error of the mean, n = 3. 
hibition by the Met46Ala mutation might result from dif- 
ferences between the two cell types in the basic machinery 
for endocytosis. To examine this possibility,  a control ex- 
periment  was  performed  using  another  rapidly  internal- 
ized  membrane  protein,  the  polymeric  immunoglobulin 
receptor (plgR).  The plgR is normally expressed  in mu- 
cosal epithelia and has two strong tyrosine-dependent en- 
docytosis signals  in its  cytoplasmic domain  (Okamoto  et 
al., 1992). A  Tyr668Cys,Tyr734Ser double mutation destroys 
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Figure  11.  The  SVTS  promotes  VAMP-TAg  endocytosis  in 
CHO cells. (a) Endocytosis of VAMP-TAg in transiently trans- 
fected CHO cells  was measured as in Fig.  3.  (b)  Inhibition of 
VAMP-TAg endocytosis by the Met46Ala mutation in CHO and 
PC12 cells. The fraction of [125I]-KT3  internalized during 3 min at 
37°C was measured for cells transfected with VAMP-TAg and 
the Met46Ala mutant and the percentage of endocytosis inhibited 
by the  mutation  was calculated.  Six  independent  experiments 
were performed with CHO cells and three independent experi- 
ments were performed with PC12 cells. Error bars represent the 
standard error of the mean. 
these two endocytosis signals, pIgR internalization was in- 
hibited by 57% in both PC12 and CHO cells by this muta- 
tion (Fig. 12). Mutation of only the Tyr734 signal had an in- 
termediate effect of identical magnitude in both cell types. 
These results imply that the basic machinery for internal- 
ization and recognition of standard endocytosis signals is 
identical in PC12 and CHO cells and cannot account for 
the  differential  effect  of  the  Met46Ala  mutation  on 
VAMP-TAg endocytosis in the two cell types. 
Discussion 
Synaptic  vesicle  proteins  present  on  the  presynaptic 
plasma membrane after exocytosis are rapidly internalized 
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Figure 12. Endocytosis  of the 
pIgR is inhibited to an equiva- 
lent extent in PC12 and CHO 
ceils by mutations  in tyrosine- 
dependent  endocytosis  sig- 
nals.  PC12 and  CHO  cells 
were transfected  with  expres- 
sion vectors for the wild-type 
and mutant forms of the pIgR. 
Endocytosis  was measured as 
in  Fig. 6  with  radioiodinated 
FAB fragments  of a polyclonal 
plgR antibody. 
via coated pits to regenerate synaptic vesicles (Miller and 
Heuser, 1984;  Matteoli et al.,  1992; Maycox et al., 1992). 
Endocytosis of VAMP-2  cannot  be  measured,  however, 
because it cannot be labeled from outside the cell by mem- 
brane impermeable reagents since it does not have an ex- 
tracellular domain. To overcome this difficulty, a modified 
form of VAMP-2 was constructed with a COOH-terminal 
T  antigen  epitope  tag  and  a  spacer  containing  three 
lysines. The engineered protein, VAMP-TAg, was labeled 
at the surface of transfected cells and tracked with remark- 
ably consistent results using two independent techniques, 
binding  of the  monoclonal  antibody  KT3  and  covalent 
coupling of biotin. The use of radioiodinated KT3 allows 
for a  quantitative assay for VAMP-TAg endocytosis be- 
cause over 90% of the antibody can be stripped from the 
cell surface by an acidic wash. Endocytosis of VAMP-TAg 
in  PC12  cells is  rapid  and insensitive to potential cross- 
linking by bivalent KT3. 
The  rapid  rate  of  VAMP-TAg  endocytosis  in  PC12/ 
VAMP-TAg cells is consistent with the expected pathway 
of internalization via clathrin coated pits. Further support 
for the involvement of coated pits is the observation that 
inhibition of clathrin assembly by incubation of VAMP- 
TAg transfected CHO cells in hypertonic media (Hansen 
et al.,  1993) inhibits  [125I]-KT3 internalization by greater 
than 90%  (unpublished observation). There is,  however, 
no direct morphological evidence for clustering of VAMP- 
TAg in coated pits. 
VAMP-TAg endocytosis is  retarded if the transfected 
protein is expressed at levels substantially higher than the 
native expression level of VAMP-2. Inhibiting endocytosis 
of VAMP-TAg by overexpression causes an accumulation 
of the  protein on the  plasma  membrane  indicating  that 
transport of VAMP-TAg to the plasma membrane is not 
similarly inhibited. This result implies that  a  component 
with limited availability is required for rapid VAMP-TAg 
endocytosis. The limiting factor might be  a  protein with 
specificity for VAMP-TAg or a general component of the 
endocytosis machinery. 
The saturation hypothesis can explain some puzzling ob- 
servations about other synaptic vesicle proteins. For exam- 
ple, the fraction of synaptophysin that  is  internalized in 
PC12 cells is less than that of the transferrin and mannose- 
6-phosphate receptors (Green and  Kelly, 1992)  and also 
less than the extent of synaptophysin endocytosis in CHO 
cells (Linstedt and Kelly, 1991). These observations might 
be related to the fact that synaptophysin is naturally ex- 
pressed at high levels compared with other synaptic vesicle 
proteins in PC12 cells (Clift-O'Grady et al., 1990). Satura- 
tion may also explain why synaptotagmin, a protein known 
to have a  high affinity binding site for the AP2 adaptor 
protein  complex  of  clathrin  coated  pits  (Zhang  et  al., 
1994), is  predominantly found associated with actin-rich 
filopodia on the surface of transfected CHO cells (Feany 
and  Buckley,  1993).  A  similar  staining  pattern  was  ob- 
served for VAMP-TAg in a  CHO cell line with high ex- 
pression (unpublished observation). 
Intracellular  Distribution  of VAMP-TAg 
We have previously reported that VAMP-TAg is targeted 
to  synaptic vesicles in  transfected PC12  cells.  However, 
only a small fraction of the total protein is recovered in the 
synaptic vesicle peak (Grote et al., 1995). Immunofluores- 
cent  microscopy  of  transfected  PC12  cells  shows  that 
VAMP-TAg  is  targeted  to  punctate  organelles  concen- 
trated  around  the  nucleus.  KT3  monoclonal  antibody 
bound to VAMP-TAg at the cell surface and internalized 
for 5 min is sorted to organelles with an intracellular distri- 
bution similar to that of VAMP-TAg at steady-state sug- 
gesting that the protein is primarily targeted to early endo- 
somes. Although similar staining patterns have also been 
observed for the transferrin receptor (an early endosome 
marker) and for synaptophysin (a synaptic vesicle protein 
that is also found in early endosomes) no definitive con- 
clusions can be drawn from this data because of the low 
resolution  of  immunofluorescent  microscopy  and  the 
rounded shape of PC12 cells. 
Other  organelles  that  might  contain  VAMP-TAg  in- 
clude vesicles of the constitutive and regulated secretory 
pathways. VAMP  has recently been shown to be a  sub- 
strate for a novel SRP-independent mechanism for insert- 
ing COOH-terminal anchored proteins into the endoplas- 
mic reticulum (Kutay et al., 1995).  In agreement with this 
report, we have found that an O-linked glycan is added to 
a  site in the spacer domain of VAMP-TAg with kinetics 
consistent with modification in the endoplasmic reticulum 
and Golgi apparatus as VAMP-TAg is transported through 
the  secretory pathway  (unpublished  observation).  How- 
ever, only a  small  fraction  of the  total  VAMP-TAg  at 
steady state is likely to be in early compartments of the 
secretory pathway since the fraction of VAMP-TAg that is 
glycosylated reaches a  plateau within  1 h  after synthesis 
whereas the half-life of the protein is greater than 2 d. An- 
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granules since a fraction of the VAMP-2 endogenously ex- 
pressed  by PC12  cells  is  targeted  to  secretory granules 
(Chilcote  et  al.,  1995;  Papini  et  al.,  1995).  None  of the 
VAMP-TAg  mutations  blocked  transport  through  the 
secretory pathway to the cell surface. 
Role of the SVTS in Endocytosis 
The central finding of this study is that the only mutations 
in VAMP-TAg that inhibit endocytosis are located within 
the  predicted  amphipathic  a-helix  centered  on  methio- 
nine-46 that we have previously identified as the synaptic 
vesicle targeting signal  (SVTS).  Endocytosis of VAMP- 
TAg was inhibited by deleting segments of the helix or by 
substituting  alanine  for amino  acids  on its  hydrophobic 
face. The SVTS of VAMP-TAg is unlike previously identi- 
fied endocytosis signals.  It is  distinct from the tyrosine- 
based signals of the transferrin and LDL receptors because 
it does not contain aromatic amino acids and is predicted 
to form an e~-helix, not a  [3-turn.  The difference between 
the SVTS and the dileucine signals found in CD3 and the 
MHC class II invariant chain is more subtle. The sequence 
of the SVTS fits the consensus for di-leucine signals be- 
cause it has an acidic amino acid, glutamate-41, four amino 
acids NH2-terminal of a di-hydrophobic pair (Pond et al., 
1995).  However, alanine scanning mutagenesis of di-leu- 
cine signals does not result in a helical pattern of inhibi- 
tion. Furthermore, the Glu41Ala and Ile45Ala mutations of 
VAMP-TAg did not inhibit endocytosis. 
The unique features of the SVTS as an endocytosis sig- 
nal allow for the possibility that the SVTS may promote 
endocytosis by a novel mechanism rather than binding to 
adaptors in coated pits. We previously suggested that the 
SVTS is required for binding to another synaptic vesicle 
protein that escorts VAMP-TAg to synaptic vesicles. Simi- 
larly, we now propose that VAMP binds, via the SVTS, to 
an escort protein that carries it from the cell surface to en- 
dosomes. Colocalization of the signals for endocytosis and 
synaptic vesicle targeting suggests that a single escort pro- 
tein remains bound to VAMP-TAg throughout the synap- 
tic vesicle recycling process. One implication of this model 
is  that  the  principal  interaction  required  for  targeting 
VAMP-TAg to synaptic vesicles occurs at the cell surface. 
Alternatively, there may be a family of v-SNARE escort 
proteins that bind to the SVTS. In PC12 cells, one escort 
protein would be responsible for endocytosis and another 
for synaptic vesicle targeting. The synaptic vesicle escort 
could bind to VAMP-TAg either in endosomes or at the 
plasma membrane. A third escort protein could be respon- 
sible for endocytosis of both VAMP-TAg and cellubrevin 
in  CHO  cells.  This  multiple  escort  protein  model  can 
readily account for the differences between the effects on 
endocytosis and synaptic vesicle targeting of some muta- 
tions in the SVTS. For example, the Asn49Ala  mutation 
enhances synaptic vesicle targeting, but does not affect en- 
docytosis. Also, the ValsoAla mutation completely blocks 
synaptic vesicle  targeting  but  only partially  inhibits  en- 
docytosis. If there are multiple escort proteins, binding to 
the synaptic vesicle escort is likely to be more sensitive to 
inhibition by asparagine-49 or mutations on the hydropho- 
bic  face  of  the  helix.  Similarly,  the  escort  protein  ex- 
pressed  in  CHO  cells  could  be  less  sensitive  to  the 
Met46Ala mutation than its counterpart in PC12 cells. 
The differential effects of some mutations on endocyto- 
sis and synaptic vesicle targeting can also be explained by 
elaborating the single escort protein model. The main fea- 
ture of the new model is that VAMP-TAg will recycle to 
the plasma membrane before it is sorted to synaptic vesi- 
cles if it dissociates from its escort in endosomes. Thus, the 
Asn49Ala mutant is sorted more efficiently to synaptic ves- 
icles because it has a higher affinity for the escort protein, 
but the ValsoAla mutant is internalized but not targeted to 
synaptic vesicles because its affinity for the escort protein 
is low. An additional postulate of this model is that the af- 
finity of wild-type VAMP-TAg for the escort protein is al- 
ready sufficient for the maximum possible rate of endocy- 
tosis.  Therefore,  the  enhanced  binding  affinity  of  the 
Asn49Ala mutant does not increase its rate of endocytosis. 
The incomplete inhibition of endocytosis in CHO cells 
by  the  Met46Ala  mutation  indicates  that  there  are  cell 
type-dependent differences in endocytosis of VAMP-TAg. 
Differences in the basic machinery for endocytosis cannot 
be responsible for this  observation because  mutation of 
the  tyrosine-dependent endocytosis signals  of the  plgR 
has an equivalent inhibitory effect on the internalization 
rate in PC12 and CHO cells. Cell type-specific differences 
in the effect of mutations on endocytosis have also been 
observed for a  tyrosine-dependent signal in the LDL re- 
ceptor (Davis et al., 1987; Matter et al., 1994) and a dileu- 
cine-based signal  in the invariant chain (Odorizzi et al., 
1994; Pond et al., 1995), but the cause of these differences 
is unknown. One explanation for the cell type-dependent 
differences in  endocytosis of the  Meh6Ala  VAMP-TAg 
mutant  is  that  CHO  and  PC12  cells  express  different 
v-SNARE  escort proteins  as  suggested  earlier.  Alterna- 
tively, if both cell types use the same v-SNARE escort pro- 
tein for endocytosis, VAMP-TAg might have a secondary 
endocytosis signal active only in CHO cells that is respon- 
sible for endocytosis of the Met46Ala mutant. This second- 
ary endocytosis signal could be inactive in PC12 cells ei- 
ther  because  PC12  cells do not  express the  appropriate 
endocytosis machinery or because its activity is inhibited. 
The  enhanced  internalization  rate  observed for the  del 
2-31  mutant suggests that the NH2-terminal variable do- 
main could be responsible for inhibiting endocytosis. Ab- 
sence of an NH2-terminal inhibitory domain can also ex- 
plain the rapid internalization without an SVTS by the del 
2-60 mutant in PC12 cells. 
The overlap that we have discovered between the en- 
docytosis and synaptic vesicle targeting signals in the cyto- 
plasmic domain of VAMP-TAg is analogous to the over- 
lap that has previously been reported between endocytosis 
signals and signals for targeting either to the basolateral 
surface of polarized epithelial cells or to late endosomes. 
The relationship between overlapping signals for endocy- 
tosis and basolateral targeting in the Fc and LDL recep- 
tors has been extensively studied (Matter et al., 1994).  In 
the case of the Fc receptor the two dileucine signals  are 
apparently identical. In contrast, the overlapping signals in 
the LDL receptor both require a critical tyrosine but are 
otherwise completely distinct. Many of the mutations in 
the cytoplasmic domain of VAMP-TAg have different ef- 
fects  on  endocytosis and  synaptic  vesicle  targeting,  but 
The Journal of Cell Biology, Volume 132, 1996  546 thus far the differences observed have been quantitative 
rather than qualitative. Thus, it is not certain whether a 
single  escort protein  binding  to  the  SVTS  can  promote 
both endocytosis and synaptic vesicle targeting or whether 
multiple escort proteins are necessary. Future experiments 
will be directed towards the identification of proteins that 
interact with VAMP-TAg via the SVTS. 
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